Pacific Biosciences of California, Inc. (PACB)
NASDAQ · Healthcare
Pacific Biosciences of California, Inc. EBITDA 2009–2025
Pacific Biosciences of California, Inc. annual/quarterly ebitda history and growth rate from 2011 to 2018. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Pacific Biosciences of California, Inc. annual ebitda for 2018 was -93.8 M, a 15.28% increase from 2017.
- Pacific Biosciences of California, Inc. annual ebitda for 2017 was -81.3 M, a 20.74% increase from 2016.
- Pacific Biosciences of California, Inc. annual ebitda for 2016 was -67.4 M, a 164.64% increase from 2015.
- Pacific Biosciences of California, Inc. annual ebitda for 2015 was -25.5 M.
No data available.
Pacific Biosciences of California, Inc. EBITDA — FAQ
Pacific Biosciences of California, Inc. (PACB) ebitda over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PACB's ebitda history?
The chart and table above show Pacific Biosciences of California, Inc.'s ebitda by year and by quarter, including the growth rate.